Skip to main content
22 November 2024
Last updated:
Monday 18 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
US Special Protocol Assessments for Oncology
Read more
European biotechs start to look undervalued
Read more
An interview with Thomas Lönngren -- Managing change at the EMA
Read more
JAK2 inhibitors: a breakthrough in oncology?
Read more
European Commission lifts funding for innovation
Read more
Boehringer Ingelheim opts for nimble approach
Read more
Affimed brings new antibody to the clinic
Read more
$2 billion in new US funding
Read more
Competition intensifies for cancer treatments
Read more
When is the right time for Pharma to develop stem cell technology
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
69
Page
70
Page
71
Page
72
Current page
73
Page
74
Page
75
Page
76
Page
77
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
